Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
ExcelCSVXML     print

4Alexis Elbaz

 

Key Opinion Leader In [Alexis Elbaz is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

  • 273Parkinson Disease | 768Case-Control Studies

Keywords (32) [keywords assigned to Alexis Elbaz articles by PubMed, the leading number and the color conveys importance]

  • 4Humans | 3Male | 3Female | 3Middle Aged | 3Aged | 3Parkinson Disease | 3Adult | 3Case-Control Studies | 2Adolescent | 2Genotype | 2Polymorphism, Genetic | 2Genetic Predisposition to Disease | 2Aged, 80 and over | 2Smoking | 1Environmental Exposure | 1Nitric Oxide Synthase Type II | 1Stroke | 1Neutrophils | 1Brain Infarction | 1Nitrates | 1Peroxidase | 1Base Sequence | 1Survival Analysis | 1Nitric Oxide Synthase | 1Age of Onset | 1Odds Ratio | 1Alleles | 1Insurance, Health | 1Nitric Oxide Synthase Type I | 1Cohort Studies | 1Minnesota | 1Age Factors

Other [context-specific ads]

Alexis Elbaz Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Alexis Elbaz might be a good expert witness on these terms]

  • 11polymorphisms | 9study | 9ci | 9allele | 9polymorphism | 8association | 8mpo | 8pd | 7nnos | 7carriers | 7patients | 6parkinson | 6bi | 6disease | 5brain | 4functional | 4g-129a | 4risk | 4outcome | 4case-control | 4genes | 4smoking | 4g-463a | 4community-based | 3myeloperoxidase | 3infarct | 3infarction | 3inos | 3controls | 3size | 3age | 2subjects
  • 6parkinson disease | 5carriers allele | 4mpo polymorphisms | 4community-based case-control | 4case-control study | 4confidence interval | 4polymorphism confidence | 3functional outcome | 3brain infarction | 3g-129a polymorphism | 3polymorphisms brain | 3allele g-129a | 3years rr | 3patients pd | 3allele g-463a | 3rr ci | 3g-463a polymorphism | 2genes community-based | 2polymorphisms nnos | 2association infarct | 2inos genes | 2infarct size | 2disease polymorphisms | 2size functional | 2association parkinson | 2myeloperoxidase polymorphisms | 2nnos inos | 2age-dependent relationship | 2ci 08-2 | 2study parkinson | 2olmsted county | 2risk developing
  • 4community-based case-control study | 4polymorphism confidence interval | 3polymorphisms brain infarction | 3allele g-129a polymorphism | 3allele g-463a polymorphism | 3years rr ci | 2myeloperoxidase polymorphisms brain | 2inos genes community-based | 2size functional outcome | 2nnos inos genes | 2association parkinson disease | 2polymorphisms nnos inos | 2association infarct size | 2genes community-based case-control | 2disease polymorphisms nnos | 2infarct size functional | 2parkinson disease polymorphisms | 2g-129a polymorphism confidence | 2g-463a polymorphism confidence | 2parkinson disease olmsted | 2evidence age-dependent relationship | 2olmsted county minnesota | 2disease olmsted county | 2gene parkinson disease | 2exon nnos carriers | 2bi carriers allele | 2survival study parkinson | 2uch-l1 gene parkinson | 2study parkinson disease | 2carriers allele ci | 2polymorphism uch-l1 gene | 2nnos carriers allele